HQH

abrdn Healthcare Investors

16.29 USD
+0.26
1.62%
At close Dec 20, 4:00 PM EST
After hours
16.41
+0.12
0.74%
1 day
1.62%
5 days
-4.23%
1 month
-8.07%
3 months
-13.35%
6 months
-3.44%
Year to date
-3.44%
1 year
1.56%
5 years
-23.05%
10 years
-48.87%
 

About: abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

15% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 33

6% more funds holding

Funds holding: 109 [Q2] → 115 (+6) [Q3]

6.27% less ownership

Funds ownership: 32.38% [Q2] → 26.11% (-6.27%) [Q3]

14% less capital invested

Capital invested by funds: $273M [Q2] → $234M (-$39M) [Q3]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for HQH.

Financial journalist opinion

Neutral
Seeking Alpha
1 week ago
11 Closed-End Fund Buys In The Month Of November 2024
This month, I've added to 11 different positions, but most of these were related to repurchases after the BlackRock tender offers. While I added to 11 different positions, these were all positions I had already held previously, so there were no new positions this month. In fact, I sold out of a fund to consolidate my holdings and reduce the number of funds held, as I did last month as well.
11 Closed-End Fund Buys In The Month Of November 2024
Positive
Seeking Alpha
3 weeks ago
2 Cyber Monday Picks I Am Buying Hand Over Fist
Buy income streams on sale, and collect your rewards for decades to come. I collect income from the market, not just cash from selling positions. Let the market fund your life; don't just dismantle your life savings.
2 Cyber Monday Picks I Am Buying Hand Over Fist
Positive
Seeking Alpha
1 month ago
HQH: Declines Bring Potential Opportunity
HQH has seen pressure recently due to regulatory uncertainty; while the closed-end funds discount has actually narrowed, it could be an interesting place to put some capital to work. The fund's 12% managed distribution policy has attracted interest from yield investors, though a quarterly pay may be less appealing. HQH's portfolio is tilted toward a heavier weight in biotech, with top holdings like Gilead Sciences showing resilience while others like Regeneron and Eli Lilly have struggled.
HQH: Declines Bring Potential Opportunity
Neutral
Seeking Alpha
1 month ago
Worried About A Recession? Income Solutions With Yields Up To 13%
Time in the market trumps timing the market, but the timing of your retirement matters. In retirement, you need a portfolio capable of providing reliable income and mitigating sequence of return risk. We discuss two robust picks geared to provide steady income in retirement.
Worried About A Recession? Income Solutions With Yields Up To 13%
Positive
Seeking Alpha
3 months ago
HQH: High Yielding Exposure To Biotech With Positive Outlook
abrdn Healthcare Investors operates as a closed end fund that aims to provide total returns comprised of high current income. HQH offers a high-yielding dividend rate of 12.7% and distributions are paid out on a monthly basis. The fund's focus on biotech holdings makes it vulnerable to interest rate changes but also positions it for potential growth with lower rates.
HQH: High Yielding Exposure To Biotech With Positive Outlook
Positive
Seeking Alpha
4 months ago
Retire With Dividends: 2 Picks With Yields Up To 12%
The prospects of a failed retirement are only heightened by a recession at the start of your retirement. Change the fuel behind your retirement finances with dividends vs. capital withdrawals. Unlock up to 12% yields with these income opportunities.
Retire With Dividends: 2 Picks With Yields Up To 12%
Neutral
Accesswire
4 months ago
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE American:FAX)(NYSE American:FCO)(NYSE American:IAF)(NYSE American:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equity Fund, Inc. (JEQ) which will pay on September 30, 2024, to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024).
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
Positive
Seeking Alpha
5 months ago
HQH: Discount Remains Attractive With A Now Higher Distribution Rate
The healthcare sector is traditionally defensive during economic downturns, but not all industries within the healthcare sector are created equal. abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portfolio allocated there. HQH's managed distribution policy was increased significantly since our prior update, which was a factor in the funds discount narrowing, but it continues to trade at an attractive discount.
HQH: Discount Remains Attractive With A Now Higher Distribution Rate
Positive
Seeking Alpha
5 months ago
HQH: Double-Digit Discount And Dividend Ready For Biotech Rally
HQH features a deep NAV discount at 11%, it is cheap and offers good opportunity for price appreciation. Biotech sector is showing strength in recent market rally. HQH with high yield at 13% is a good buy for income investors to participate the promising biotech rally. Record financing activities in the sector fuel the business growth and set up for a sustainable market recovery.
HQH: Double-Digit Discount And Dividend Ready For Biotech Rally
Positive
Seeking Alpha
5 months ago
Make Money While You Sleep, 2 Big Dividends For A Retirement Dream
What is your dream retirement? Make goals to achieve it. Don't make monetary number goals that can't answer the "what then?" question. I meet expenses head-on with highly valuable income.
Make Money While You Sleep, 2 Big Dividends For A Retirement Dream
Charts implemented using Lightweight Charts™